Purification and characterization of aShigellaconjugate vaccine, produced by glycoengineeringEscherichia coli-Reference-Cited by-同舟云学术

Purification and characterization of aShigellaconjugate vaccine, produced by glycoengineeringEscherichia coli

Published:2015-09-09 Issue: Volume: Page:cwv077
ISSN:0959-6658
Container-title:Glycobiology
language:en
Short-container-title:Glycobiology

Author:

Ravenscroft Neil,Haeuptle Micha A,Kowarik Michael,Fernandez Fabiana S,Carranza Paula,Brunner Andreas,Steffen Michael,Wetter Michael,Keller Sacha,Ruch Corina,Wacker Michael

Funder

NRF South Africa/Switzerland Science and Technology Agreement

Medical Research Council

Publisher

Oxford University Press (OUP)

Subject

Biochemistry

Link

http://academic.oup.com/glycob/article-pdf/26/1/51/17485793/cwv077.pdf

Reference46 articles.

1. Isolation and characterization of lipopolysaccharides;Apicella;Methods Mol Biol (Clifton, NJ),2008

2. Surveillance for Bacterial Diarrhea and Antimicrobial Resistance in Rural Western Kenya, 1997-2003

3. Prospective cohort studies of shigellosis during military field training;Cohen;Eur J Clin Microbiol Infect Dis,2001

4. NMR spectroscopy, molecular dynamics, and conformation of a synthetic octasaccharide fragment of the O-specific polysaccharide of Shigella dysenteriae type 1

5. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive characterization of bacterial glycoconjugate vaccines by liquid chromatography - mass spectrometry;Carbohydrate Polymers;2024-10

2. Establishing a Cell-Free Glycoprotein Synthesis System for Enzymatic N-GlcNAcylation;ACS Chemical Biology;2024-06-27

3. Three-component systems represent a common pathway for extracytoplasmic addition of pentofuranose sugars into bacterial glycans;Proceedings of the National Academy of Sciences;2024-05-15

4. Shigella Vaccines: The Continuing Unmet Challenge;International Journal of Molecular Sciences;2024-04-13

5. A platform for the recombinant production of Group A Streptococcus glycoconjugate vaccines;2024-03-02